Edgewise Therapeutics, Inc.

This early-stage study tests an experimental drug called EDG-15400 in 108 healthy adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo by mouth, and researchers measure side effects and drug levels in blood and urine. The st…

This early-stage study looks at how a single dose of the experimental drug EDG-7500 is processed by the body in people with mild or moderate liver impairment compared to those with normal liver function. About 32 adults will participate to measure drug levels in the blood and che…